Cargando…

Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer

OBJECTIVE: Limited data have been obtained in regard to pulmonary metastasis (PM) in patients with stage I endometrial cancer. The aims of the study were (1) to present the clinical and pathological characteristics of patients with PM in the setting of stage I endometrioid-type endometrial cancer (E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Wei, Chen, Jun, Tao, Xiang, Huang, Feifei, Zhu, Menghan, Wang, Chao, Feng, Weiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Uterine Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499968/ https://www.ncbi.nlm.nih.gov/pubmed/28448305 http://dx.doi.org/10.1097/IGC.0000000000001002

Ejemplares similares

Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma
por: Wang, Fangfang, et al.
Publicado: (2017)

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas
por: Ytre-Hauge, Sigmund, et al.
Publicado: (2015)

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
por: Lan, Chunyan, et al.
Publicado: (2015)

Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016)

The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible
por: Girda, Eugenia, et al.
Publicado: (2017)

Increased Association Between Endometriosis and Endometrial Cancer: A Nationwide Population-Based Retrospective Cohort Study
por: Yu, Hann-Chin, et al.
Publicado: (2015)

Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
por: Taurin, Sebastien, et al.
Publicado: (2018)

Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial (AGO-GYN5)
por: Emons, Günter, et al.
Publicado: (2014)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

Revaluating the survival effects of International Federation of Gynecology and Obstetrics 1988 stage IIIA criteria for endometrial cancer
por: Türkmen, Osman, et al.
Publicado: (2017)

Relationships of nuclear, architectural and International Federation of Gynecology and Obstetrics grading systems in endometrial cancer
por: Toptaş, Tayfun, et al.
Publicado: (2018)

Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters
por: Xiao, Yao, et al.
Publicado: (2023)

Global Work of the International Federation of Gynecology and Obstetrics (FIGO)
por: Serour, G.I.
Publicado: (2012)

Whether intermediate-risk stage 1A, grade 1/2, endometrioid endometrial cancer patients with lesions larger than 2 cm warrant lymph node dissection?
por: Zhu, Menghan, et al.
Publicado: (2017)

International Federation of Gynecology and Obstetrics Global Declaration on Cervical Cancer Elimination
Publicado: (2019)

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
por: Jamieson, Amy, et al.
Publicado: (2023)

Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems
por: Shin, Wonkyo, et al.
Publicado: (2021)

Endometrioid endometrial adenocarcinoma in a premenopausal woman with multiple organ metastases
por: Srikantia, Nirmala, et al.
Publicado: (2009)

Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study
por: Ayhan, Ali, et al.
Publicado: (2018)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage
por: Huang, Ru, et al.
Publicado: (2020)

Images in infectious diseases in obstetrics and gynecology. Endometrial tuberculosis.
por: Korn, A P, et al.
Publicado: (2000)

Endometrioid endometrial cancer “recurring” as high-grade serous adenocarcinoma in the inguinal lymph nodes in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
por: Jiang, Wei, et al.
Publicado: (2019)

Prognostic Analysis and Comparison of the 2014 and 2018 International Federation of Gynecology and Obstetrics Staging System on Overall Survival in Patients with Stage IIB-IVA Cervix Carcinoma
por: Song, Tao, et al.
Publicado: (2022)

Improving Global Outcomes in Cervical Cancer: The Time Has Come for International Federation of Gynecology and Obstetrics Staging to Formally Incorporate Advanced Imaging
por: Jolly, Shruti, et al.
Publicado: (2017)

Prognostic Factors and Local Treatment Modalities of Small-Cell Carcinoma of the Cervix: An Analysis According to the International Federation of Gynecology and Obstetrics Stage [Corrigendum]
Publicado: (2020)

Interest In and Practices Related to Gynecologic Oncology among Members of the Brazilian Federation of Associations of Gynecology and Obstetrics
por: Júnior, Arilto Eleutério da Silva, et al.
Publicado: (2019)

Hypoxia and Angiogenesis in Endometrioid Endometrial Carcinogenesis
por: Horrée, Nicole, et al.
Publicado: (2007)

VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022)

Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists
por: Rabban, Joseph T., et al.
Publicado: (2019)

Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial
por: Hu, Yingjie, et al.
Publicado: (2022)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

Localized endometrioid cancer in the abdominal wall with synchronous early-stage endometrial cancer
por: Şahin, Orhan, et al.
Publicado: (2021)

New ground breaking International Federation of Gynecology and Obstetrics's classification of abnormal uterine bleeding: Optimizing management of patients
por: Sharma, Jai Bhagwan, et al.
Publicado: (2013)

Multisite gynecologic endometrioid adenocarcinomas: Can mutation profiling be used to distinguish synchronous primary cancers from metastases?
por: Barnes, Dominique, et al.
Publicado: (2022)

Neoadjuvant chemotherapy followed by surgery has no therapeutic advantages over concurrent chemoradiotherapy in International Federation of Gynecology and Obstetrics stage IB-IIB cervical cancer
por: Lee, Jeongshim, et al.
Publicado: (2016)

Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer
por: Soochit, Ashvin, et al.
Publicado: (2023)

Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sdmoen6lr35clv5384mikatmnn